{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:43:28Z","timestamp":1784303008321,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009448","name":"University of Campania \"Luigi Vanvitelli\"","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.vph.2020.106822","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T02:16:59Z","timestamp":1605925019000},"page":"106822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells"],"prefix":"10.1016","volume":"137","author":[{"given":"Giovanni","family":"Cimmino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Cal\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vph.2020.106822_bb0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","article-title":"Acute coronary syndromes: the way forward from mechanisms to precision treatment","volume":"136","author":"Crea","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2020.106822_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","article-title":"Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis","volume":"84","author":"Di Pietro","year":"2016","journal-title":"Vasc. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2020.106822_bb0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000200440","article-title":"Genesis and dynamics of atherosclerotic lesions: implications for early detection","volume":"27","author":"Badimon","year":"2009","journal-title":"Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.ATV.0000253884.13901.e4","article-title":"Implications of early structural-functional changes in the endothelium for vascular disease","volume":"27","author":"Simionescu","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2020.106822_bb0025","doi-asserted-by":"crossref","first-page":"152786","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"11","key":"10.1016\/j.vph.2020.106822_bb0030","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1161\/CIRCRESAHA.107.101105","article-title":"LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice","volume":"100","author":"Morawietz","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9343(99)00153-9","article-title":"Cellular adhesion molecules and atherogenesis","volume":"107","author":"Price","year":"1999","journal-title":"Am. J. Med."},{"issue":"11","key":"10.1016\/j.vph.2020.106822_bb0040","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/ATVBAHA.107.149179","article-title":"Vascular adhesion molecules in atherosclerosis","volume":"27","author":"Galkina","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1573403X12666161014093812","article-title":"Immune-inflammatory activation in acute coronary syndromes: a look into the heart of unstable coronary plaque","volume":"13","author":"Cimmino","year":"2017","journal-title":"Curr. Cardiol. Rev."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1160\/TH14-05-0451","article-title":"The adipokine apelin-13 induces expression of prothrombotic tissue factor","volume":"113","author":"Cirillo","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cardiores.2005.05.010","article-title":"C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation","volume":"68","author":"Cirillo","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2020.106822_bb0060","doi-asserted-by":"crossref","first-page":"25171","DOI":"10.1038\/srep25171","article-title":"Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation","volume":"6","author":"Stojkovic","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V99.1.199","article-title":"Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK\/EGR-1 and ca(++)\/NFAT","volume":"99","author":"Bochkov","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.vph.2020.106822_bb0070","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine--update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"22","key":"10.1016\/j.vph.2020.106822_bb0075","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMp1003126","article-title":"Incentives for drug development--the curious case of colchicine","volume":"362","author":"Kesselheim","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.vph.2020.106822_bb0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.vph.2020.106822_bb0085","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/01.mjt.0000433937.07244.e1","article-title":"Colchicine: new insights to an old drug","volume":"22","author":"Stack","year":"2015","journal-title":"Am. J. Ther."},{"issue":"42","key":"10.1016\/j.vph.2020.106822_bb0090","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.vph.2020.106822_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1074248418778548","article-title":"The utility of anti-inflammatory agents in cardiovascular disease: a novel perspective on the treatment of atherosclerosis","volume":"23","author":"Kottoor","year":"2018","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.vph.2020.106822_bb0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40256-017-0226-3","article-title":"Teaching an old dog new tricks: colchicine in cardiovascular medicine","volume":"17","author":"Chen","year":"2017","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"26","key":"10.1016\/j.vph.2020.106822_bb0105","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"9B","key":"10.1016\/j.vph.2020.106822_bb0110","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/j.1582-4934.2008.00614.x","article-title":"Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano)","volume":"13","author":"Cimmino","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2020.106822_bb0115","first-page":"1","article-title":"Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel","author":"Cirillo","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.vph.2020.106822_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.vph.2018.09.004","article-title":"Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1","volume":"111","author":"Cimmino","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2020.106822_bb0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2016.04.177","article-title":"Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: a possible contribution of immunity to thrombosis?","volume":"218","author":"De Palma","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ijcard.2012.10.040","article-title":"C-reactive protein induces expression of matrix metalloproteinase-9: a possible link between inflammation and plaque rupture","volume":"168","author":"Cimmino","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2014.05.005","article-title":"Regulation of tissue factor gene expression in monocytes and endothelial cells: thromboxane A2 as a new player","volume":"62","author":"Bode","year":"2014","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11739-010-0423-4","article-title":"Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?","volume":"6","author":"Cimmino","year":"2011","journal-title":"Intern. Emerg. Med."},{"issue":"6","key":"10.1016\/j.vph.2020.106822_bb0145","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/cvr\/cvz230","article-title":"Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1","volume":"116","author":"Cimmino","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2020.106822_bb0150","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcp.2016.12.016","article-title":"Nobiletin inhibits oxidized-LDL mediated expression of tissue factor in human endothelial cells through inhibition of NF-kappaB","volume":"128","author":"Cirillo","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0155","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.17.2.365","article-title":"Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B\/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression","volume":"17","author":"Oeth","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.vph.2020.106822_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/bbrc.1998.9004","article-title":"Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells","volume":"248","author":"Mehta","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.vph.2020.106822_bb0165","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.20.4.1116","article-title":"Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors","volume":"20","author":"Li","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cardiores.2004.07.002","article-title":"Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells","volume":"64","author":"Mehta","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"1 Suppl","key":"10.1016\/j.vph.2020.106822_bb0175","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.10.013","article-title":"The pathology of atherosclerosis: plaque development and plaque responses to medical treatment","volume":"122","author":"Insull","year":"2009","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.vph.2020.106822_bb0180","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heartjnl-2017-311446","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2006.07.007","article-title":"The dietary soy flavonoid genistein abrogates tissue factor induction in endothelial cells induced by the atherogenic oxidized phospholipid oxPAPC","volume":"120","author":"Holzer","year":"2007","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.vph.2020.106822_bb0190","doi-asserted-by":"crossref","first-page":"581","DOI":"10.21037\/cdt.2018.10.14","article-title":"Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis","volume":"8","author":"Cimmino","year":"2018","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"8","key":"10.1016\/j.vph.2020.106822_bb0195","doi-asserted-by":"crossref","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Martinez","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.vph.2020.106822_bb0200","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.vph.2020.106822_bb0205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/cbin.10988","article-title":"Colchicine, a microtubule-disassembling drug, in the therapy of cardiovascular diseases","volume":"42","author":"Chaldakov","year":"2018","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2006-10-050476","article-title":"Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling","volume":"110","author":"Mandal","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.vph.2020.106822_bb0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0955-0674(00)00123-X","article-title":"Connecting vesicle transport to the cytoskeleton","volume":"12","author":"Kamal","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0038-1657623","article-title":"Regulation of the tissue factor gene","volume":"78","author":"Mackman","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.vph.2020.106822_bb0225","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","article-title":"Nuclear factor kappaB signaling in atherogenesis","volume":"25","author":"de Winther","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.vph.2020.106822_bb0230","first-page":"341","article-title":"Nuclear transcription factor NF-kappa B: role in biology and medicine","volume":"42","author":"Aggarwal","year":"2004","journal-title":"Indian J. Exp. Biol."},{"issue":"2","key":"10.1016\/j.vph.2020.106822_bb0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tibs.2003.12.003","article-title":"IkappaB kinases: key regulators of the NF-kappaB pathway","volume":"29","author":"Yamamoto","year":"2004","journal-title":"Trends Biochem. Sci."},{"issue":"19","key":"10.1016\/j.vph.2020.106822_bb0240","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1016\/j.yexcr.2009.08.020","article-title":"Microtubule-mediated NF-kappaB activation in the TNF-alpha signaling pathway","volume":"315","author":"Jackman","year":"2009","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.vph.2020.106822_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","article-title":"Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders","volume":"69","author":"Mehta","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2020.106822_bb0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.lfs.2018.02.024","article-title":"LOX-1 receptor: a potential link in atherosclerosis and cancer","volume":"198","author":"Balzan","year":"2018","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.vph.2020.106822_bb0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10557-011-6322-8","article-title":"LOX-1 transcription","volume":"25","author":"Hermonat","year":"2011","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912030327X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912030327X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:19:38Z","timestamp":1761527978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718912030327X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":51,"alternative-id":["S153718912030327X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2020.106822","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2020.106822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106822"}}